<div id="readability-page-1"><div><p>[WASHINGTON] The US Department of Justice (DOJ) is probing market volatility at a Hong-Kong based traditional Chinese medicine company after a stock surge briefly made its value soar 46,000 per cent.</p><p>The DOJ sent a subpoena to Regencell Bioscience to turn over documents and communications concerning trading in the company’s shares “and other corporate operational, financial and accounting matters”, according to the company’s financial report filed with the US Securities and Exchange Commission on Friday (Oct 31) in Washington.</p><p>“We are cooperating with this investigation, but we cannot predict its ultimate resolution,” the filing states. Company representatives didn’t immediately respond to a request for comment sent after business hours on Friday. A spokesperson for DOJ also didn’t immediately respond to a request for comment.</p><p>Regencell made headlines in June when its stock price soared despite no apparent news from the company, which markets and licenses traditional treatments for ADHD and autism spectrum disorder. The rally briefly vaulted its chief executive officer’s net worth to among the world’s largest fortunes.</p><p>The firm, which debuted on the Nasdaq Capital Market in 2021, is in the research and development stage and has not generated any revenue in any years since, according to its filing.</p><p>“We have no saleable products and have not generated any revenue from product sales,” it states.</p><p>The company addressed the volatility in its securities filing. “We believe this volatility may be caused in substantial part by a ‘short squeeze’ or other anomalous trading activity causing demand for, and price of, our ordinary shares to increase,” it said. BLOOMBERG</p></div></div>

腦再生科技

<p>美國司法部正在調查總部位於香港的傳統中醫藥公司腦再生科技，該公司的股票上漲了 46,000%。司法部已發出傳票，要求提供與交易和公司事務相關的文件。腦再生科技自 2021 年在納斯達克上市以來未產生收入，認為股價波動可能與潛在的空頭擠壓或異常交易活動有關。該公司正在配合調查，但無法預測調查結果</p>

美國司法部正在調查一家股價飆升 46,000% 的草藥公司的交易活動